Balsalazide Disodium Hydrate

巴柳氮钠

Report date: 2023/03/06 17:18:15
NME

Base Information

Drug NameBalsalazide Disodium Hydrate
Drug Alias NameBasazyde巴柳氮钠水合物balsalazidebalsalazidumBalsalazide disodium +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ antagonistsArachidonate 5-lipoxygenase inhibitorsCyclooxygenases inhibitors
TargetsPeroxisome proliferator-activated receptor γArachidonate 5-lipoxygenaseCyclooxygenases
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsColitis, Ulcerative
Approved Indications in ChinaColitis, Ulcerative
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1997/01/01
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSalix Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesSalix PharmaceuticalsBausch Health Companies IncHubei Biocause Heilen Pharmaceutical Co Ltd
Inactive CompaniesMylan Pharmaceuticals IncBausch Health Americas Inc
Active IndicationsColitis, Ulcerative
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeA07EC04
Related LinksWikipediaDrugBankKEGG